Tenaya Therapeutics, Inc. Marketable Securities (Current)
Tenaya Therapeutics, Inc. (TNYA) had Marketable Securities (Current) of $114.96 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecuritiesCurrent · last filed 2022-11-10
- 2022-09-30: Marketable Securities, Current $114.96M.
- 2022-06-30: Marketable Securities, Current $149.91M.
- 2022-03-31: Marketable Securities, Current $184.48M.
- 2021-12-31: Marketable Securities, Current $213.17M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-09-30 | $114.96M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $149.91M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $184.48M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $213.17M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $163.39M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |